Michael Machuzak, MD
Pulmonary Disease · Cleveland, OHNPI 1851355085
Payments from drug & device makers
Across 466 payments — averaging $837.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$182K
- Johnson & Johnson$105K
- Medical Device Business Services, Inc.$22K
- Ethicon Endo-surgery Inc.$20K
- Olympus America Inc.$18K
- Pulmonx Corporation$18K
- plus $26K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 259 | $181,680 |
| Johnson & Johnson(2 entities) | 49 | $105,079 |
| Medical Device Business Services, Inc. | 32 | $22,272 |
| Ethicon Endo-surgery Inc. | 6 | $19,906 |
| Olympus America Inc. | 29 | $17,659 |
| Pulmonx Corporation | 20 | $17,569 |
| Olympus Medical Systems Corporation | 4 | $7,150 |
| Serpex Medical Inc | 6 | $6,625 |
| Body Vision Medical Inc. | 10 | $4,543 |
| Gyrus ACMI, Inc. | 6 | $3,630 |
| Olympus Corporation | 3 | $1,043 |
| Noah Medical Corporation | 6 | $650 |
| Boston Scientific | 15 | $646 |
| Intuitive Surgical | 4 | $450 |
| Veran Medical Technologies, Inc. | 1 | $440 |
| Merit Medical Systems Inc | 1 | $350 |
| Auris Health, Inc. | 3 | $227 |
| Getinge USA Sales, LLC | 3 | $159 |
| Ambu Inc. | 1 | $118 |
| Covidien LP | 4 | $114 |
| Philips North America LLC | 1 | $97 |
| ICU Medical Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
| Medtronic | 1 | $12 |
How this compares
$390,447 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Cleveland
- Kristin HighlandCleveland$3.2M
- Leslie TolleCleveland$1M
- Rodney FolzCleveland$733K
- Marie BudevCleveland$658K
- Joseph ParambilCleveland$586K
- Douglas ConradCleveland$461K
- Daniel CulverCleveland$456K
- Elliott DasenbrookCleveland$456K
- Gustavo Heresi DavilaCleveland$357K
- Joseph CiceniaCleveland$350K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.